好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Coping Styles and Quality of Life in Patients with Psychogenic Non-Epileptic Seizures (PNES): A South African Perspective
Behavioral Neurology
P05 - (-)
119
BACKGROUND: Previous research suggests that avoidance coping is a prominent coping strategy for PNES patients. Moreover, research indicates that HRQOL is significantly lower in PNES patients when compared to ES patients and healthy control groups. However, no research that studied the association between specific coping styles and HRQOL of PNES patients could be found.
DESIGN/METHODS: Twenty-two PNES patients with confirmed video EEG were matched by age and gender with a healthy control group. Participants had to complete self-reported measures of HRQOL and coping strategies (the Ways of Coping (WOC) and the Coping Strategy Indicator (CSI)). Data analysis consisted of performing Chi-square tests, Pearson correlations, analysis of variances and regression analysis.
RESULTS: The results indicated that the HRQOL of the PNES group were significantly lower than the HRQOL of the healthy control group. The PNES participants utilised significantly more emotion-focused coping strategies, such as escape-avoidance and distancing coping strategies, in comparison to the healthy control group. The WOC and the CSI accounted respectively for 56% and 42% of the variance in the HRQOL of the sample. The results also indicated that the escape-avoidance coping strategies utilised by PNES participants had a significant negative effect on their HRQOL.
CONCLUSIONS: The findings of this study provided greater insight into the coping strategies utilised by PNES participants, which have been identified as a risk factor in PNES. It also highlights that the type of coping strategies utilised by the PNES participants in our sample had a significant negative influence on their level of HRQOL. This is the first study of this nature on people with PNES in South Africa.
Authors/Disclosures
Gretha Cronje
PRESENTER
No disclosure on file
No disclosure on file
Timothy Cunniff, PharmD Dr. Cunniff has received personal compensation for serving as an employee of Paragon Biosciences. Dr. Cunniff has stock in Harmony Biosciences. Dr. Cunniff has stock in Emalex Biosciences.
Jeffrey L. Saver, MD, FAAN (UCLA Health) Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stryker. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerenovus. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boehringer Ingelheim (prevention only). Dr. Saver has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Medical Association. Dr. Saver has received stock or an ownership interest from Rapid Medical.
Jeffrey L. Saver, MD, FAAN (UCLA Health) Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stryker. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerenovus. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boehringer Ingelheim (prevention only). Dr. Saver has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Medical Association. Dr. Saver has received stock or an ownership interest from Rapid Medical.